Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Medical Facilities CorporationTSX: DR.TO

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA declines year over year

Q1 FY2026 EBITDA of $15.06M fell 16.9% year over year, behind the -3.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 27.6% from the prior quarter. Over 3 fiscal years it compounded at +5.1% a year.

Context

  • EBITDA amounted to 23.0% of revenue in FY2025, down 1.9 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of $76.61M (+28.9%) for the fiscal year ending Dec 2026, a step up from the -28.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.06M-27.6% QoQ
Last fiscal yearDec 2025
$59.41M-28.1% YoY
LTMMar 2026
$75.52M-3.6% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-16.9%-55.0%-38.1 pp
1 year-28.1%+28.9%+57.0 pp
3-year CAGR+5.1%+4.0%-1.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
59.41M USD
Year-over-year change
-28.1%
4-year CAGR
-12.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How DR.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -3.6% is the 7th highest of 9, against a peer median of +35.5%.
  • EBITDA amounts to 24.7% of revenue for DR.TO, versus a peer median of 20.4%.
DR.TO Competitors
EBITDA for DR.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$75.52M USD-3.6%+5.1%24.7%
TSND.TOTerrAscend Corp.LTM Mar 2026$60.46M USD+510.4%—23.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$49.15M CAD+45.8%—31.0%
CRRX.TOCareRx CorporationLTM Mar 2026CA$30.12M CAD+25.2%—8.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$5.36M USD+48.2%—10.5%
PRN.TOProfound Medical Corp.LTM Mar 2026-$36.45M USD-1.4%—194.3%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$40.84M CAD-681.4%—14.9%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$44.63M USD-141.2%——
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$63.48M CAD+86.8%—20.4%
Peer median (excluding DR.TO) —+35.5%—20.4%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.